CLINICAL EVOLUTION OF RARE VARIANTS OF ALPHA-1 ANTITRYPSIN DEFICIENCY IN ROMANIA

https://www.doi.org/10.22551/MSJ.2021.01.09

  • DAVIDESCU Lavinia University of Medicine and Pharmacy, Oradea
  • POSTOLACHE Paraschiva A. “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • ULMEANU Ruxandra University of Medicine and Pharmacy, Oradea
  • FIRA MLADINESCU O. “Victor Babes” University of Medicine and Pharmacy, Timisoara
  • LAZAR L. University of Medicine and Pharmacy, Oradea
  • RAJNOVEANU Ruxandra Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca
  • MAN Milena Adina “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca

Abstract

Alpha-1 Antitrypsin deficiency (AATD) is a genetic inherited autosomal dominant condition, characterized by decreased serum and pulmonary level of alpha-1 antitrypsin, affecting the lung, liver, rarely skin, associated with an increased risk of emphysema and chronic obstructive pulmonary disease (COPD) early in life, under 40. Under the minimum protection value of Alpha-1 Antitrypsin (AAT) (11 μmol/L or 80 mg /dL), neutrophil elastase may cause the alveolar septa destruction with the early appearance of pulmonary emphysema. Although, AAT is a highly pleomorphic glycoprotein, due by mutations Z and S of approximately 120 alleles. At least 30 AAT alleles other than PI*Z or PI*S were described in literature, some of them as single cases. The prevalence of rare genotypes, other than PI*ZZ or PI*SZ, is between 11% and 21.3%. These rare genotypes were recorded in areas with low prevalence of PI*Z. Rare genotypes of AATD with low plasma levels are Mprocida, Mpalermo, Q0isola di procida, Q0trastevere, Mmalton, Harleen, etc. These evolve clinically with severe emphysema with early onset between 30-40 years. The use in screening programs of gene sequencing for exons 2-5 of SERPINA-1, when genotyping demonstrates the absence of the Z and S alleles, will allow in the coming years to identify several cases of rare variants. Rare variants of alpha1 antitrypsin should be considered on the same risk for emphysema as PI*ZZ.

Author Biographies

DAVIDESCU Lavinia, University of Medicine and Pharmacy, Oradea

Faculty of Medicine

POSTOLACHE Paraschiva A., “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)
Clinical Rehabilitation Hospital, Pulmonary Rehabilitation Clinic, Iasi

ULMEANU Ruxandra, University of Medicine and Pharmacy, Oradea

Faculty of Medicine

FIRA MLADINESCU O., “Victor Babes” University of Medicine and Pharmacy, Timisoara

Faculty of Medicine

LAZAR L., University of Medicine and Pharmacy, Oradea

Faculty of Medicine

RAJNOVEANU Ruxandra, Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca

Faculty of Medicine
Department of Medical Sciences- Pulmonology

MAN Milena Adina, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca

Faculty of Medicine
Department of Medical Sciences- Pulmonology

References

1. American Thoracic Society, European Respiratory Society: American Thoracic Society / European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900 / doi: 10.1164/ rccm. 168.7.818.
2. Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency, and its clinical consequences. Orphanet J Rare Dis 2008; 3: 16 / doi: 10.1186/1750-1172-3-16.
3. Ferrarotti I, Baccheschi J, Zorzetto M, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet 2005; 42(3): 282-287 / doi: 10.1136/jmg.2004.023903.
4. Ferrarotti I, Thun GA, Zorzetto M, et al. Serum levels and genotype distribution of alpha1-antitrypsin in the general population. Thorax 2012; 67: 669-674 / doi: 10.1136/thoraxjnl-2011-201321.
5. Zaharie AM, Antoniu S, Wynimo JC, et al. Romanian Pilot study of Alpha1 Antitrypsin – Detection, Feasibility and Challenges. Rev Chim 2018; 69(5): 1152-1155.
6. Blanco I, de Serres FJ, Cárcaba V, Lara B, Fernández-Bustillo E. Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method. Hepat Mon 2012; 12(10 HCC): e7434 / doi: 10.5812/hepatmon.7434.
7. Cox DW, Levison H. Emphysema of early onset associated with a complete deficiency of alpha-1 antitrypsin (null homozygotes). Am Rev Respir Dis 1988; 137(2): 371-375 / doi: 10.1164/ajrccm/ 137.2. 371.
8. Ferrarotti I, Baccheschi J, Zorzetto M, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet 2005; 42(3): 282-287 / doi: 10.1136/jmg.2004.023903.
9. Dawkins PA, Dawkins CL, Wood AM, Nightingale PG, Stockley JA, Stockley RA. Rate of progres-sion of lung function impairment in α1-antitrypsin deficiency. Eur Resp J 2009; 33(6): 1338-1344 / doi: 10.1183/09031936.00061208.
10. Needham M, Stockley RA. Exacerbations in α1-antitrypsin deficiency. Eur Resp J 2005; 25 (6): 992-1000 / doi: 10.1183/09031936.05.00074704.
11. Dowson LJ, Guest PJ, Stockley RA. Longitudinal changes in physiological, radiological, and health status measurements in α (1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med 2001; 164:1805-1809.
12. Takahashi H, Nukiwa T, Satoh K, et al. Characterization of the gene and protein of the alpha1-antitrypsin “deficiency” allele MProcida. J Biol Chem 1988; 263: 15528-15534.
13. Maddaloni V, Pepe N, Morano F, et al. Alpha 1 antitrypsin deficiency: a rare allele in patients from south of Italy. J Lung Pulm Respir Res 2019; 6(2): 32-35 / doi: 10.15406/jlprr.2019.06.002.
14. Figueira Gonçalves JM, Martínez Bugallo F, García-Talavera I, Rodríguez González J. Déficit de alfa-1-antitripsina asociado a alelos nulos. Arch Bronconeumol 2017; 53: 700-702.
15. Luisetti M, Ferrarotti I, Corda L, et al. Italian Registry of Patients with Alpha-1 Antitrypsin Deficiency: General Data and Quality of Life Evaluation. COPD 2015; 12(Supp1. 1): 52-57 / doi: 10.3109/ 15412555.2015.1023393.
16. Piras B, Ferrarotti I, Lara B, et al. Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. Eur Respir J 2013; 42 (1): 54-64 / doi: 10.1183/09031936.00104712.
17. Stoller JK. Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency. UpToDate Jul 13, 2020.
18. Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J 2017; 50: 1700610 / doi: 10.1183/13993003.00610-2017.
Published
2021-03-30
Section
INTERNAL MEDICINE - PEDIATRICS